[Frontalis suspension with polytetrafluorethylene for the treatment of blepharoptosis].
OBJECTIVE
To evaluate the functional results and complications of the use of expanded polytetrafluoroethylene in frontalis suspension surgery for the treatment of blepharoptosis.


METHODS
Frontalis suspension procedure with polytetrafluoroethylene was performed between 2003 and 2007 on 23 patients (36 eyes) with blepharoptosis. An average follow-up time was 15.8 months (range, 3 to 36). Surgical technique used was described by Fox.


RESULTS
The causes of blepharoptosis found were: congenital in 20 patients (86.95%), blepharophimosis in 2 (8.69%) and traumatic in 1 (4.35%). At the first week of postoperatory 6 (26.08%) patients related palpebral asymmetry, 4 (17.39%) noticed local edema, 3 (13.04%) presented granulomas and 1 (4.35%) presented facial cellulitis on the ipsilateral frontal region. After 3 months of follow-up 3 (13.04%) patients related palpebral asymmetry and 1 (4.35%) persisted the granuloma.


CONCLUSIONS
Polytetrafluoroethylene - Model CV3, 6.0 (Gore-tex(R), W.L. Gore & Associates Inc, Flagstaff, AZ, EUA) is an adequate material with good functional results (86.9%), relatively few complications (4.35%) and insatisfaction (13.4%) that could be an alternative for fascia lata in the surgery of frontalis suspension for the treatment of blepharoptosis.
Silvério
Juliana
J
Setor de Plástica Ocular do Departamento de Oftalmologia da Faculdade de Medicina do ABC - Santo André (SP) - Brasil. julianasilverio@yahoo.com.br
Sugano
Débora Mayumi
DM
Lucci
Lúcia Miriam Dumont
LM
Rehder
José Ricardo Carvalho Lima
JR
D000293:Adolescent; D000328:Adult; D001763:Blepharoptosis / Q000209:etiology / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D005143:Eyelids / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009801:Oculomotor Muscles / Q000601:surgery*; D017060:Patient Satisfaction; D011138:Polytetrafluoroethylene / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
D011138:Polytetrafluoroethylene